Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Hair and nails can indicate selenium levels in the body.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

SJS and TEN can cause long-term organ damage and psychological issues beyond skin and eye problems.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Karunjchirakam Chooranam significantly improved symptoms in most PCOS cases.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The treatment improved hair growth in people with male pattern baldness.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

A new type of mite caused hair loss in a koala, which was treated successfully with ivermectin.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.